يعرض 1 - 1 نتائج من 1 نتيجة بحث عن '"Christopher S.R. Dakhil"', وقت الاستعلام: 0.34s تنقيح النتائج
  1. 1
    Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)

    المؤلفون: Anil Shanker, Millie Das, Melissa Lynne Johnson, David P. Carbone, Henry N. Wagner, Joan H. Schiller, Christopher S.R. Dakhil, Leora Horn, Maria Teresa P. de Aquino, Suresh S. Ramalingam, David E. Gerber, Ju Whei Lee, Mohammed Ali Al-Nsour, Jyoti D. Patel, Jane Jijun Liu

    المصدر: Clin Lung Cancer

    مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, genetic structures, Paclitaxel, Bevacizumab, Phases of clinical research, Adenocarcinoma of Lung, Cancer Vaccines, Article, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Membrane Glycoproteins, business.industry, Chemoradiotherapy, Middle Aged, Prognosis, Survival Rate, Regimen, 030104 developmental biology, chemistry, Tolerability, 030220 oncology & carcinogenesis, Carcinoma, Large Cell, Tecemotide, Female, Immunotherapy, business, Follow-Up Studies, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b35242c45b0100e618176be85fa4dbe
    https://doi.org/10.1016/j.cllc.2020.06.007

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء